01/20/2024
YOUR Dr. Lora Brown... presenting this weekend at the North American Neuromodulation Society (NANS).
Her demonstration highlights the Axon AT- PDN study TruWell Health participated in, which contributed to the recent FDA expanded coverage for painful diabetic neuropathy.
https://www.facebook.com/neuralace/posts/pfbid0xbPktcuaAKxz3t2AtA6qgeRngbtLygtgdzYWrYs3AdBKn2RsP95PsGY7o26PZDBFl
https://neuronewsinternational.com/neuralace-announces-us-fda-clearance-for-axon-therapy-ahead-of-nans-2024/
https://www.fiercebiotech.com/medtech/neuralace-weaves-new-diabetic-neuropathy-indication-noninvasive-nerve-stimulation-tech